CD8A and melanoma: Moreover, TIMP-1 was also added into the BMDC culture in combination with a vesicle-enriched tumor-conditioned media (EV-TCM) from 72-h cultured B16F10 melanoma cells, known for effectively enriching melanoma antigens for MHC-I-mediated CD8 + T cell priming [54].